Distinct patterns of cytolytic T‐cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization
暂无分享,去创建一个
Yannick Hamon | Mathieu Fallet | Y. Hamon | C. Billaudeau | C. Boyer | Cyrille Billaudeau | M. Fallet | M. Buferne | N. Auphan-Anezin | G. Verdeil | Nathalie Auphan-Anezin | Anne-Marie Schmitt-Verhulst | Grégory Verdeil | Melissa Frick | Pierre Mouchacca | Michel Buferne | Claude Boyer | Pierre Mouchacca | M. Frick | A. Schmitt-Verhulst | Grégory Verdeil
[1] H. Eisen,et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.
[2] Fabian Kiessling,et al. Vascular normalization in Rgs5-deficient tumours promotes immune destruction , 2008, Nature.
[3] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[4] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[5] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[6] A. Rao,et al. Calcium signaling in lymphocytes. , 2008, Current opinion in immunology.
[7] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[8] D. Segal,et al. Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysis , 1990, International journal of cancer.
[9] H. Fehling,et al. Faithful activation of an extra‐bright red fluorescent protein in “knock‐in” Cre‐reporter mice ideally suited for lineage tracing studies , 2007, European journal of immunology.
[10] Michael Loran Dustin,et al. Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Boyer,et al. Visualization of Cytolytic T Cell Differentiation and Granule Exocytosis with T Cells from Mice Expressing Active Fluorescent Granzyme B , 2013, PloS one.
[12] I. Huijbers,et al. Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice. , 2010, Cancer research.
[13] H. Pircher,et al. A Critical Requirement of Interferon γ-mediated Angiostasis for Tumor Rejection by CD8+ T Cells , 2003 .
[14] James C. Whisstock,et al. Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.
[15] M. Buferne,et al. Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells? , 2013, Pigment cell & melanoma research.
[16] I. Huijbers,et al. Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene , 2012, The Journal of Immunology.
[17] L. Leserman,et al. Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma. , 2012, Cancer research.
[18] A. Tsun,et al. The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse , 2009, Immunity.
[19] S. Spicuglia,et al. Active STAT5 Regulates T-bet and Eomesodermin Expression in CD8 T Cells and Imprints a T-bet–Dependent Tc1 Program with Repressed IL-6/TGF-β1 Signaling , 2013, The Journal of Immunology.
[20] G. Griffiths,et al. Secretory mechanisms in cell-mediated cytotoxicity. , 2007, Annual review of cell and developmental biology.
[21] S. Jameson,et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. , 2001, Immunity.
[22] Clemens Utzny,et al. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] Hai-Tao He,et al. Barcoding T Cell Calcium Response Diversity with Methods for Automated and Accurate Analysis of Cell Signals (MAAACS) , 2013, PLoS Comput. Biol..
[24] A. Lanzavecchia,et al. Serial triggering of many T-cell receptors by a few peptideMHC complexes , 1995, Nature.
[25] M. Mescher,et al. ICAM‐1 and B7‐1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM‐1 , 1999, European journal of immunology.
[26] S. Rosenberg,et al. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.
[27] C. Robert,et al. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. , 2008, Cancer research.
[28] Arup K Chakraborty,et al. Understanding the Structure and Function of the Immunological Synapse , 2010 .
[29] C. Nguyen,et al. CD8 T Cell Help for Innate Antitumor Immunity1 , 2007, The Journal of Immunology.
[30] Roxana Khazen,et al. Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse , 2016, Nature Communications.
[31] C. Nguyen,et al. CD 8 T Cell Help for Innate Antitumor Immunity 1 , 2007 .
[32] R Y Tsien,et al. Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets. , 1987, The EMBO journal.
[33] P. Coulie,et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy , 2014, Nature Reviews Cancer.
[34] R. Penner,et al. STIM2 drives Ca2+ oscillations through store‐operated Ca2+ entry caused by mild store depletion , 2013, The Journal of physiology.
[35] I. Hwang,et al. LFA-1-dependent Ca2+ Entry following Suboptimal T Cell Receptor Triggering Proceeds without Mobilization of Intracellular Ca2+* , 2009, The Journal of Biological Chemistry.
[36] I. Caramalho,et al. Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation , 2008, Journal of cellular and molecular medicine.
[37] S. H. van der Burg,et al. Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response , 2014, Science Translational Medicine.
[38] Thomas M. Schmitt,et al. T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma. , 2015, Cancer cell.
[39] A. Schmitt‐Verhulst,et al. Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T‐cell receptor diversity , 2010, Immunology.
[40] A. Fischer,et al. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules , 2010, Nature Reviews Immunology.
[41] K. Schwarz,et al. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis , 2011, Proceedings of the National Academy of Sciences.
[42] Jérôme Galon,et al. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. , 2013, Immunity.
[43] A. Cooke. Infection and autoimmunity. , 2009, Blood cells, molecules & diseases.
[44] S. Feske,et al. Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity , 2012, The Journal of physiology.
[45] J. Lieberman,et al. Perforin pores in the endosomal membrane trigger release of endocytosed granzyme B to the cytosol of target cells , 2011, Nature Immunology.
[46] R. Emerson,et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.
[47] M. Hoth,et al. Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. , 2013, Biochimica et biophysica acta.
[48] L. Leserman,et al. IFNγ producing CD8+ T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas , 2015, Oncoimmunology.
[49] T. Mak,et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.
[50] M. Davis,et al. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. de Waal Malefyt,et al. CD2/LFA‐3 or LFA‐l/ICAM‐1 but not CD28/B7 interactions can augment cytotoxicity by virus‐specific CD8+ cytotoxic T lymphocytes , 1993, European journal of immunology.
[52] I. Huijbers,et al. An inducible mouse model of melanoma expressing a defined tumor antigen. , 2006, Cancer research.
[53] R. Flavell,et al. Emerging Roles of L-Type Voltage-Gated and Other Calcium Channels in T Lymphocytes , 2013, Front. Immunol..
[54] Bin Zhang,et al. IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. , 2008, The Journal of clinical investigation.
[55] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[56] P. Chomez,et al. Thymocyte-Intrinsic Genetic Factors Influence CD8 T Cell Lineage Commitment and Affect Selection of a Tumor-Reactive TCR1 , 2004, The Journal of Immunology.
[57] Weiyang Jin,et al. Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing , 2016, Cell.
[58] Michael W. Davidson,et al. Actin Depletion Initiates Events Leading to Granule Secretion at the Immunological Synapse , 2015, Immunity.
[59] W. Jefferies,et al. Tweeters, Woofers and Horns: The Complex Orchestration of Calcium Currents in T Lymphocytes , 2015, Front. Immunol..
[60] D. Morgan,et al. The Role of Intercellular Adhesion Molecule-1/LFA-1 Interactions in the Generation of Tumor-Specific CD8+ T Cell Responses1 , 2005, The Journal of Immunology.
[61] David Kotlyar. CD8 T Cells , 2016 .
[62] C. Nguyen,et al. STAT5-Mediated Signals Sustain a TCR-Initiated Gene Expression Program toward Differentiation of CD8 T Cell Effectors1 , 2006, The Journal of Immunology.
[63] R. Flavell,et al. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis , 2009, Proceedings of the National Academy of Sciences.
[64] C. Uyttenhove,et al. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.
[65] R. Holcombe,et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. , 1996, Cellular immunology.
[66] C. Uyttenhove,et al. The shared tumor‐specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection , 1998, European journal of immunology.